gemcitabine
A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
Chemical structure
| Molecular formula | C9H11F2N3O4 |
|---|---|
| Charge | 0 |
| Average mass | 263.2 Da |
| Monoisotopic mass | 263.07176 Da |
| Source | ChEBI |
| InChIKey | SDUQYLNIPVEERB-QPPQHZFASA-N |
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1
Also called
- gemcitabina
- gemcitabinum
- 2'-deoxy-2',2'-difluorocytidine
- 2',2'-Difluorodeoxycytidine
- 2'-Deoxy-2',2'-difluorocytidine
- 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
Cross-references
- beilstein:5382060
- cas:95058-81-4
- kegg.compound:C07650
- lincs.smallmolecule:LSM-5333
- pdb-ccd:GEO
- reaxys:5382060
Drug registries
Patents and articles
- patent:EP1939198
- patent:EP2108368
- patent:EP2275135
- patent:GB2136425
- patent:US2009124797
- patent:US2010111852
- patent:US4808614
- wikipedia.en:Gemcitabine
Activity roles
- antiviral drug
CHEBI:36044
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:175901 |
gemcitabine | antibioticmech:chebi-809a134577 |
2026-08-30 |
Mechanism summary
- Mode of action
- NUCLEIC_ACID_SYNTHESIS_INHIBITION host shared target
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories